Arcturus Therapeutics Holdings Inc (ARCT)
27.15
-0.39
(-1.42%)
USD |
NASDAQ |
May 08, 11:37
Arcturus Therapeutics Holdings Enterprise Value: 449.59M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 449.59M |
| May 06, 2024 | 443.67M |
| May 03, 2024 | 442.32M |
| May 02, 2024 | 422.13M |
| May 01, 2024 | 459.56M |
| April 30, 2024 | 396.54M |
| April 29, 2024 | 425.09M |
| April 26, 2024 | 422.93M |
| April 25, 2024 | 412.70M |
| April 24, 2024 | 434.51M |
| April 23, 2024 | 460.09M |
| April 22, 2024 | 436.67M |
| April 19, 2024 | 407.39M |
| April 18, 2024 | 416.55M |
| April 17, 2024 | 452.08M |
| April 16, 2024 | 519.12M |
| April 15, 2024 | 497.04M |
| April 12, 2024 | 527.02M |
| April 11, 2024 | 583.82M |
| April 10, 2024 | 564.98M |
| April 09, 2024 | 560.13M |
| April 08, 2024 | 540.48M |
| April 05, 2024 | 568.47M |
| April 04, 2024 | 531.60M |
| April 03, 2024 | 589.20M |
| Date | Value |
|---|---|
| April 02, 2024 | 575.20M |
| April 01, 2024 | 598.35M |
| March 28, 2024 | 616.92M |
| March 27, 2024 | 592.43M |
| March 26, 2024 | 572.78M |
| March 25, 2024 | 644.37M |
| March 22, 2024 | 620.42M |
| March 21, 2024 | 599.70M |
| March 20, 2024 | 600.23M |
| March 19, 2024 | 616.65M |
| March 18, 2024 | 599.70M |
| March 15, 2024 | 685.29M |
| March 14, 2024 | 686.90M |
| March 13, 2024 | 728.08M |
| March 12, 2024 | 749.34M |
| March 11, 2024 | 727.81M |
| March 08, 2024 | 700.09M |
| March 07, 2024 | 708.97M |
| March 06, 2024 | 724.85M |
| March 05, 2024 | 718.93M |
| March 04, 2024 | 721.35M |
| March 01, 2024 | 773.87M |
| February 29, 2024 | 747.85M |
| February 28, 2024 | 785.94M |
| February 27, 2024 | 861.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
40.68M
Minimum
Jun 18 2019
2.771B
Maximum
Dec 22 2020
496.38M
Average
394.31M
Median
May 22 2023
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.827M |
| Perspective Therapeutics Inc | 1.072B |
| Protalix BioTherapeutics Inc | 58.97M |
| Electromed Inc | 140.24M |
| Armata Pharmaceuticals Inc | 172.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.71M |
| Revenue (Quarterly) | 25.08M |
| Total Expenses (Quarterly) | 43.35M |
| EPS Diluted (Quarterly) | -0.32 |
| Profit Margin (Quarterly) | -46.68% |
| Earnings Yield | -3.83% |
| Normalized Earnings Yield | -8.394 |